Sections from post-mortem tissue of a person with Alzheimer’s disease (AD) with abundant neurofibrillary tangles and of a person with frontotemporal lobar degeneration (FTLD) with severe TDP-43 pathology were used as positive controls for the staining procedure. This evidence concerns the gene TARDBP and Alzheimer disease.